Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal cancer care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Jeannie Ferris Award
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events

Pancreatic cancer

pancreatic-mm cancer-types/pancreatic-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Treatment
Loading...

Treatment options

  • Printer-friendly version
  • A|A

Treatment and care of people with cancer is usually provided by a team of health professionals, both medical and allied health, called a multidisciplinary team.

Treatment for pancreatic cancer depends on:

  • the stage of the disease
  • the location of the cancer
  • the severity of symptoms
  • your general health and wishes.

Treatment may involve the following.

Surgery

Surgery may be used to remove all the cancer, if this appears possible. If the cancer has spread too far to be removed completely, surgery may be used to relieve symptoms or prevent complications (palliative surgery).

Pancreatic neuroendocrine tumours are more likely to be resectable than exocrine cancers.

Most pancreatic cancers have spread beyond the pancreas by the time they are diagnosed. These cancers are not able to be fully removed by surgery. The chance of successful removal of all the cancer is greatest for pancreatic neuroendocrine tumours and cancers in the head (widest part) of the pancreas. Cancers in the head of the pancreas often cause jaundice because they can press against the bile duct, causing bile to build up in the liver. The symptoms of jaundice mean that they can be detected early enough to be removed.

Surgery for pancreatic cancer usually involves a pancreaticoduodenectomy (Whipple procedure). This removes the head of the pancreas, and may also remove the body of the pancreas, part of the small intestine, part of the bile duct, the gallbladder, lymph nodes near the pancreas and part of the stomach. The surgeon then connects the remaining parts of the bile duct, pancreas, small intestine and stomach so that digestion of food can continue. This operation usually requires a large cut down the middle of the abdomen, although laparoscopic (keyhole) surgery may be possible in some cases, especially for pancreatic neuroendocrine tumours.

Because this is a major, complex operation, there can be complications, including leakage from the surgical connections, infections, bleeding, problems with the stomach emptying after eating, weight loss, changes in bowel habits and diabetes.

Other types of surgery for pancreatic cancer involve removing the tail (thinnest part) of the pancreas and the spleen (distal pancreatectomy); or removing the whole pancreas, the spleen, part of the small intestine, the bile duct, the gallbladder, lymph nodes near the pancreas and part of the stomach (total pancreatectomy). Total pancreatectomy is not common. It results in diabetes because it removes the insulin-producing cells, and insulin injections are needed to maintain blood sugar levels. Pills containing pancreatic enzymes are also needed to enable digestion of certain foods.

Palliative surgery (to relieve symptoms but not to destroy the cancer) may be required if the cancer is blocking the common bile duct, which passes through the head of the pancreas. Blockage of the bile duct can also be relieved by placing a small tube called a stent inside the bile duct to keep it open. Another option is bypass surgery, which reroutes the bile from the common bile duct into the small intestine, bypassing the blocked part of the duct.

Ablation and embolisation

Ablation uses treatment with heat (radiowaves or microwaves that heat the cancer) or cold (cold gases that freeze the cancer) to destroy tumours. These treatments are delivered using thin probes that are guided into the cancer tissue.

Embolisation involves injection of substances into an artery to block the flow of blood to the cancer tissue, causing it to die.

Ablation and embolisation are unlikely to cure pancreatic cancer. They are most often used to relieve symptoms.

Radiotherapy

Along with surgery, some people may receive radiotherapy.

Usually, the radiation for pancreatic cancer is delivered to the cancer from a machine outside the body. Radiotherapy is more helpful for exocrine pancreatic cancer than for pancreatic neuroendocrine tumours, which do not respond well to standard radiation. Endocrine cancers can be treated with a special form of radiation that is infused or injected by a specialist such as nuclear physician.

Chemotherapy

Along with surgery, some people may receive chemotherapy.

Targeted therapy

Targeted therapy refers to treatment with medicines that are designed to specifically attack cancer cells without harming normal cells. These types of medicines affect the way that cancer cells grow, divide, repair themselves or interact with other cells.

Medicines used for targeted therapy of pancreatic cancer include sunitinib and everolimus (used for advanced pancreatic neuroendocrine tumours).

Other treatments

Other treatments that may be used for functional pancreatic neuroendocrine tumours include hormone therapy (to block the action of the excess hormones) and specific medicines to relieve the symptoms caused by the excess hormones.

Follow-up

After treatment, you might need regular physical examinations and other tests to check whether the cancer has come back (recurred) or metastasised, or to check for side effects of treatment. You might also need help to ensure that your nutritional needs are being met, because many people experience weight loss due to poor nutrition as a result of pancreatic cancer or its treatment.

Advanced disease

In stage III or stage IV pancreatic cancer, the cancer has spread too far to be removed by surgery. However, surgery may be used to relieve symptoms, or problems such as blockage of the bile duct or the intestine by pressure from the cancer.

Chemotherapy, with or without radiotherapy, is the main treatment for advanced forms of exocrine pancreatic cancer. This may shrink the tumours or slow their growth, possibly helping people to live longer.

Pancreatic neuroendocrine tumours are often slow growing. If they have spread so that they cannot be removed by surgery, medicines may be given to relieve symptoms such as diarrhoea or hormone problems. Chemotherapy or targeted therapy may be used, and surgery or ablation may be used to treat metastases in the liver.

Recurrent cancer

Pancreatic cancer can recur (come back) after treatment. Secondary cancer is when the cancer spreads to another part of the body. Secondary cancers from pancreatic cancer often develop in the liver, but they may occur in the lungs, bone or other organs.

Recurrent pancreatic cancer is treated in the same way as metastatic (stage IV) cancer – that is, with chemotherapy, and possibly other treatments to relieve symptoms.

  • Last Updated
  • References
  • Relevant Links
updated: 20 October 2020 - 3:32pm

American Cancer Society (2015). Pancreatic cancer http://www.cancer.org/cancer/pancreaticcancer/detailedguide/index.

National Comprehensive Cancer Network (2014). NCCN guidelines for patients: pancreatic cancer, version 1.2014 http://www.nccn.org/patients/guidelines/pancreatic/index.html.

National Cancer Institute (2015). Pancreatic neuroendocrine tumors (islet cell tumors) treatment (PDQ®) http://www.cancer.gov/cancertopics/pdq/treatment/isletcell/Patient, patient version.

National Cancer Institute (2015). Pancreatic cancer treatment (PDQ®) http://www.cancer.gov/cancertopics/pdq/treatment/pancreatic/Patient, patient version.

American Cancer Society, Pancreatic cancer
National Cancer Institute (US)
Pancreatic cancer action (Aus)

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia